Table 1

Hemodynamics

nHeart RateMean Blood PressureRate Pressure Product
Baseline15-min Ischemia120-min ReperfusionBaseline15-min Ischemia120-min ReperfusionBaseline15-min Ischemia120-min Reperfusion
beats/minute mm Hg mm Hg · min−1 · 1000−1
Control8368  ± 11368  ± 14410  ± 2984  ± 0477  ± 0664  ± 0839  ± 0235  ± 0237  ± 06
IPC7337  ± 14314  ± 13324  ± 151-150 108  ± 081-150 98  ± 1299  ± 071-150 45  ± 0436  ± 0541  ± 04
TAN-677343  ± 10324  ± 11380  ± 2276  ± 0568  ± 0555  ± 0535  ± 0328  ± 0328  ± 02
PD 0980595400  ± 06400  ± 17428  ± 3096  ± 1276  ± 0951  ± 0548  ± 0638  ± 0532  ± 03
PD 098059 +IPC7374  ± 20349  ± 19330  ± 161-150 115  ± 051-150 68  ± 0658  ± 0452  ± 0330  ± 0327  ± 01
PD 098059 +TAN-676335  ± 15295  ± 181-150 362  ± 0977  ± 0656  ± 0746  ± 0535  ± 0423  ± 0424  ± 02

Values given as mean ± S.E.M.

    • IPC, preconditioning induced by one cycle of 5 min of ischemia followed by 5 min of reperfusion; TAN-67, δ1-opioid agonist infused for 15 min prior to ischemia and reperfusion; PD 098059, inhibitor of MEK-1, administered in the absence or presence of IPC or TAN-67.

    • 1-150p < 0.05 vs. control.